TITLE

Incidence of end-stage renal disease in patients with type 1 diabetes was 7.8% at 30 years after diagnosis

PUB. DATE
March 2006
SOURCE
ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p51
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents a study which reveals that the incidence of end-stage renal disease (ESRD) in patients with type 1 diabetes was 7.8% at 30 years after diagnosis. During 346 851 person-years of follow-up, 632 patients developed ESRD and 1417 patients died. The cumulative incidences of ESRD were 2.2% after 20 years and 7.8% after 30 years; risks were similar in men and women and those diagnosed since 1980. Cumulative mortality was 6.8% after 20 years and 15% after 30 years. Risk for death was higher in patients who had developed ESRD than in those who had not. Risk for death was higher in men than in women, increased with age at diagnosis, and decreased with recency of diagnosis.
ACCESSION #
20297621

 

Related Articles

  • Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study.  // BMC Nephrology;2011, Vol. 12 Issue 1, p53 

    The article focuses on a multicenter study from Spanish government hospital-based nephrology outpatient clinics regarding patients with chronic kidney disease stage 3 and stage 4 in Spain. Median age was 70.9 years while morbidity from all cardiovascular disease (CVD) was very high in the cohort...

  • The importance of residual renal function in dialysis patients. Wang, A. Y.-M.; Lai, K.-N. // Kidney International;May2006, Vol. 69 Issue 10, p1726 

    Preserving residual renal function has always been the primary clinical goal for every nephrologist managing patients with chronic kidney disease. There is no reason why this important goal should not extend to patients with stage 5 chronic kidney disease receiving dialysis. Indeed, there is now...

  • COMMENTARY: Incidence of end-stage renal disease in patients with type 1 diabetes was 7.8% at 30 years after diagnosis. Winkelmayer, Wolfgang C. // ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p51 

    This article reports that researchers describes the natural history of incident patients with type 1 diabetes for more then 30 years. While one could assume that the availability of new treatment approaches would improve the long-term prognosis of patients with diabetes over time. Patients who...

  • Half-and-half nail. Wen-Te Huang; Chia-Chao Wu // CMAJ: Canadian Medical Association Journal;3/17/2009, Vol. 180 Issue 6, p687 

    The article reports on the diagnosis given to a 61-year-old man suffering from diabetes mellitus and chronic kidney disease and has a history of malaise, vomiting and nausea. The patient underwent laboratory tests where a pinkish red transverse band was observed in his fingernails. He was...

  • A Disease Haplotype for Advanced Nephropathy in Type 2 Diabetes at the ACE Locus. Ng, Daniel P. K.; Placha, Grzegorz; Serena Choo; Kee-seng Chia; Warram, James H.; Krolewski, Andrzej S. // Diabetes;Sep2006, Vol. 55 Issue 9, p2660 

    Previous investigations of the ACE gene as a susceptibility factor for diabetic nephropathy have primarily focused on its insertion/deletion (Ins/Del) polymorphism. In a departure from these earlier studies, we used three tagging markers (A-5466C, T-3892C, and Ins/Del) at the ACE locus to test...

  • Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Artery Disease, Diabetes, and Chronic Kidney Disease. Shepherd, James; Kastelein, John J. P.; Bitfner, Vera A.; Carmena, Rafael; Deedwania, Prakash C.; Breazna, Andrei; Dobson, Stephen; Wilson, Daniel J.; Zuckerman, Andrea L.; Wenger, Nanerfe K. // Mayo Clinic Proceedings;Aug2008, Vol. 83 Issue 8, p870 

    OBJECTIVE: To investigate the effect of Intensive lipid lowering with high-dose atorvastatin on the incidence of major cardiovascular events compared with low-dose atorvastatin in patients with coronary artery disease and type 2 dIabetes, with and without chronic kidney disease (CKD). PATIENTS...

  • Big-head disease: Uremic leontiasis ossea. Kumar, S.; Thuraisingham, R.; Yaqoob, M. // Kidney International;May2006, Vol. 69 Issue 10, p1709 

    The article presents a nephrology image of the big-head disease, uremic leontiasis ossea. The patient is a 46-year-old woman with known epilepsy, on long-term phenobarbitone therapy and who developed end-stage renal failure. A photograph of her, showing bulging of malar bones and widening of...

  • Chapter 16. Management of CKD.  // Clinical & Experimental Nephrology;Jun2009, Vol. 13 Issue 3, p226 

    The article explores issues related to the management of chronic kidney disease (CKD). The basic aim of CKD management is to block CKD or retard its progression to end-stage kidney disease (ESKD), which reduces the quality of life of CKD patients. Management of ESKD needs relatively costly renal...

  • Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Jones, Camille A.; Krolewski, Andrzej S.; Rogus, John; Xue, Jay L.; Collins, Allan; Warram, James H. // Kidney International;May2005, Vol. 67 Issue 5, p1684 

    Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Background. The number of individuals initiating renal replacement therapy in the United States population grew exponentially over the past two decades. Cases of end-stage renal...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics